Contributors
Latest:
QOL Similar With Checkpoint Combo Versus Single-Agent Immunotherapy in MelanomaPatients with melanoma who were treated with a combination of Opdivo and Yervoy showed no significant changes in their quality of life when compared to those who were treated with either agent alone.
Latest:
Leading the Fight Against Ovarian CancerOvarian Cancer Research Alliance (OCRA) supports women and their families going through an ovarian cancer diagnosis, while also funding the research that will one day lead to its prevention.
Latest:
Beth Sandy on Managing Chemotherapy-Induced NauseaBeth Sandy, C.R.N.P, a nurse practitioner at the Abramson Cancer Center, discusses managing chemotherapy-induced nausea.
Latest:
Building Community Partnerships to Improve Cancer OutcomesCancer care involves more than just doctors and nurses. Nadine Barrett, director of the Office of Health Equity and Disparities at the Duke Cancer Institute, knows this.
Latest:
Rafat Abonour on the Importance of Raising Awareness About MyelomaRafat Abonour, MD, professor of Medicine, pathology, and laboratory medicine at Indiana University, discusses the importance of raising awareness about multiple myeloma and his Miles for Myeloma initiative.
Latest:
Physician Turns Personal Diagnosis to Educational OpportunityBrian Koffman is a family physician who used his own CLL diagnosis to start a group that informs other patients and their loved ones.
Latest:
Combination Regimen Benefits Genitourinary CancersCabometyx combinations showed activity in patients with GU cancers, according to a preliminary clinical study.
Latest:
D. Ross Camidge Discusses Brain Metastases in Patients With Lung CancerD. Ross Camidge, director, Thoracic Oncology Clinical Program, University of Colorado Cancer Center, discusses the need for more research into brain metastases in lung cancer patients.
Latest:
Expert Discusses Therapeutic Options Taken At Home During COVID-19 PandemicDr. Jubilee Brown discussed the use of telemedicine and oral treatment options for patients with ovarian cancer, as well as offered advice to ease stress and anxiety throughout the COVID-19 pandemic.
Latest:
The Mother-Daughter Conversation You Should Have TodayTaking the extra time to have the more difficult conversations with your daughter about her breast health and breast cancer risk has the power to greatly improve and extend her own life.
Latest:
Web Exclusive: 2007 State of the State of Gynecologic CancersThe Gynecologic Cancer Foundation releases its 2007 annual report.
Latest:
The V Foundation for Cancer Research to LaunchThe American Kennel Club Donates $25,000 to Support Canine Comparative Oncology Through the V Foundation.
Latest:
Jacquelyn Powers on Empowering Patients With Information Regarding Genetic TestingJacquelyn Powers, genetic counselor, Abramson Cancer Center, University of Pennsylvania, discusses how to empower patients with information regarding genetic testing.
Latest:
An Unstoppable Force in NursingAn Extraordinary Healer essay honoring JACKIE MILLER, B.S.N., RN, OCN [PENN MEDICINE VIRTUA CANCER PROGRAM, VOORHEES, NEW JERSEY]
Latest:
Managing Cancer-Related Joint PainFor many cancer patients, joint pain subsides when treatment ends.
Latest:
Does Your Body’s Biological Clock Affect Your Treatment?How your body's biological clock could affect the success of cancer treatment.
Latest:
Aziz Nazha on Adverse Events Associated With Treatment for MDSAziz Nazha, Hematology and Medical Oncology Fellow, Cleveland Clinic, discusses adverse events associated with treatment for myelodysplastic syndrome (MDS).
Latest:
Advocating for Herself Amid Treatment for a Rare CancerOne patient with breast implant-associated anaplastic large cell lymphoma spoke out for herself throughout therapy — and encourages other patients do the same.
Latest:
Medical Illustration: Multiple MyelomaMultiple myeloma begins with a single precancerous plasma cell that multiplies uncontrollably and can eventually cause bone lesions and anemia.
Latest:
Minimal Harm Associated with Multiplex Gene Testing for Inherited Cancer RiskMultiplex gene testing may not bring about unnecessary surgery or adverse psychological effects, according to findings from a recent study.
Latest:
Novel Agents Are Changing the Prostate Cancer Treatment LandscapeThe addition of novel agents in the prostate cancer treatment landscape could create a shift in the way patients with advanced disease are treated, said Dr. Daniel George.
Latest:
Individualized Treatment Is Needed for mCRC SubsetCURE spoke with Maria Ignez Braghiroli, M.D. about the need for individualized treatment for patients with NRAS-mutant metastatic colorectal cancer.
Latest:
First LineTHE PLACE TO BE / PEOPLE REPORT / PREVENTION / INTEGRATIVE MEDICINE / LEGISLATIVE WATCH / WEB FIND / HOUSE CALL / BOOKSHELF
